BrainAurora says npj Digital Medicine publishes schizophrenia trial of self-adaptive cognitive remediation

PUBT · 3d ago
BrainAurora says npj Digital Medicine publishes schizophrenia trial of self-adaptive cognitive remediation
  • BrainAurora disclosed publication of results from a randomized, double-blind, active-controlled schizophrenia cognitive remediation trial in npj Digital Medicine.
  • Results have already been presented via journal publication, not flagged for a future conference readout.
  • Self-adaptive computerized training delivered stronger, faster cognitive gains than fixed-difficulty training, with benefits most evident in attention and speed.
  • Training also reduced positive symptoms versus control, supporting potential clinical value beyond cognition.
  • Findings back a dynamic “difficulty-performance coupling” mechanism, strengthening the company’s evidence base for its digital therapeutics platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brainaurora Medical Technology Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260902-12316506), on September 02, 2026, and is solely responsible for the information contained therein.